TiumBio
A drug developer working on treatments for cancer based in South Korean. Learn more
Launch date
Employees
Market cap
€122m
Enterprise valuation
€127m (Public information from Sep 2024)
Share price
KRW6180 321550.KQ
Seongnam-si Gyeonggi-do (HQ)
Authorizing premium user...